High-intensity interval training was associated with improved glycemic control and cardiometabolic outcomes among patients with type 2 diabetes.

Among patients with isolated systolic hypertension and frailty, antihypertensive therapy is associated with improved outcomes.

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.

DTC as second primary malignancy was associated with increased risk for cardiovascular mortality, especially for those under 75 years of age.

Weight fluctuation was associated with a greater risk for diabetic kidney disease progression among individuals with type 1 diabetes.

Content warning: This article mentions suicide. In the first days of Donald Trump’s second term as United States president, he signed 2 executive orders that carry significant, immediate implications ...

Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

In patients with acute type A aortic dissection, receiving surgical repair at a high-volume aortic center is associated with improved survival.

Mortality rates among US adults spiked from 2011 to 2019 and 2020 to 2023, remaining higher than expected based on prepandemic levels.

Researchers determined further improvements are necessary to better capture clinically useful data in a pediatric population for DOAC trials.